Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
123,180,519
-
Number of holders
-
137
-
Total 13F shares, excl. options
-
65,482,202
-
Shares change
-
-2,157,651
-
Total reported value, excl. options
-
$376,526,274
-
Value change
-
-$10,746,528
-
Put/Call ratio
-
3.48%
-
Number of buys
-
61
-
Number of sells
-
-71
-
Price
-
$5.75
Significant Holders of CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) as of Q2 2021
159 filings reported holding CPRX - CATALYST PHARMACEUTICALS, INC. - COMMON STOCK as of Q2 2021.
CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) has 137 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 65,482,202 shares
of 123,180,519 outstanding shares and own 53.16% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (10,000,000 shares), BlackRock Inc. (8,005,837 shares), STATE STREET CORP (5,998,448 shares), VANGUARD GROUP INC (4,986,222 shares), LSV ASSET MANAGEMENT (4,240,316 shares), ROYCE & ASSOCIATES LP (3,073,846 shares), PRUDENTIAL FINANCIAL INC (1,929,486 shares), GEODE CAPITAL MANAGEMENT, LLC (1,864,633 shares), DIMENSIONAL FUND ADVISORS LP (1,460,941 shares), and NORTHERN TRUST CORP (1,424,148 shares).
This table shows the top 137 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.